AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
Spring 2009
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
4
Updates in Treatment of Unresectable Hepatocellular Carcinoma
5